Alembic receives FDA final approval for Betamethasone Valerate Foam, 0.12%

Retrieved on: 2024-08-25 12:26:10

Tags for this article:

Click the tags to see associated articles and topics

Alembic receives FDA final approval for Betamethasone Valerate Foam, 0.12%. View article details on hiswai:

Excerpt

Pfizer and BioNTech receive FDA authorization for Omicron KP.2-adapted Covid-19 Vaccine · Wanbury receives EIR from FDA for Patalganga facility ...

Article found on: www.indianpharmapost.com